The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.
Le Rhun E, Bink A, Felsberg J, Gramatzki D, Brandner S, Benhamida JK, Wick A, Tonn JC, Mohme M, Tabatabai G, Capper D, Snuderl M, Razis E, Ronellenfitsch MW, Neidert N, Ng HK, Pohl U, Bale T, Quach S, Rieger D, Schüller U, Onken J, Drüschler K, Maurage CA, Regli L, Healy E, Graham M, Hortobagyi T, Paine S, Bridges L, Lausova T, Medici V, Sievers P, Schrimpf D, Wick W, Sahm F, Reifenberger G, von Deimling A, Weller M; H3 G34 DHG Study Group.
Le Rhun E, et al. Among authors: wick a.
Neuro Oncol. 2025 Jan 22:noaf015. doi: 10.1093/neuonc/noaf015. Online ahead of print.
Neuro Oncol. 2025.
PMID: 39842935